Medindia»Health Tips»
FDA Approved Brigatinib Drug For Lung Cancer Treatment
FDA Approved Brigatinib Drug For Lung Cancer Treatment
Cancers caused due to the abnormal proliferation of the cells in the lungs are referred to as Lung cancer. Around 3-5% of lung cancers are caused due to the changes in gene Anaplastic lymphoma kinase (ALK). Brigatinib drug receives approval from FDA to treat ALK-positive lung cancer as second-line therapy.
MEDINDIA
English
हिन्दी
Español
français
中文
Email
